发布时间：2024-10-23 18:22:43<源自：高蹈远举网作者：n
Sinovac vaccines induced neutralizing antibody responses to live novel coronavirus in adults aged 60 and above, according to the results from the Phase-I and Phase-II clinical trials. All adverse reactions observed among elderly groups were of mild or moderate severity. Graphic: Feng Qingyin/GT
欢迎分享转载→ Sinovac releases first vaccine trial data on seniors
